O’Donnell AE. Bronchiectasis – a clinical review. N Engl J Med. 2022;387(6):533–45.
Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880–90.
Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J. 2017;50(6):1701289.
Loebinger MR, Bilton D, Wilson R. Upper airway 2: bronchiectasis, cystic fibrosis and sinusitis. Thorax. 2009;64(12):1096–101.
Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018;18(1):83.
Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–40.
CFTR2. https://cftr2.org. Accessed 20 Jan 2025.
Grasemann H, Ratjen F. Cystic fibrosis. N Engl J Med. 2023;389(18):1693–707.
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124.
Hannah WB, Truty R, Gonzales V, Kithcart GP, Ouyang K, Zeman MK, et al. Frequency of cystic fibrosis transmembrane conductance regulator variants in individuals evaluated for primary ciliary dyskinesia. J Pediatr. 2019;215:172-7.e2.
Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations–correlation with incidence data and application to screening. Hum Mutat. 2002;19(6):575–606.
Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments. Respirology. 2015;20(8):1172–81.
Horani A, Ferkol TW. Understanding Primary ciliary dyskinesia and other ciliopathies. J Pediatr. 2021;230:15-22.e1.
Cant E, Shoemark A, Chalmers JD. Primary ciliary dyskinesia: integrating genetics into clinical practice. Curr Pulmonol Rep. 2024;13(1):57–66.
Rumman N, Jackson C, Collins S, Goggin P, Coles J, Lucas JS. Diagnosis of primary ciliary dyskinesia: potential options for resource-limited countries. Eur Respir Rev. 2017;26(143):160058.
Shoemark A, Griffin H, Wheway G, Hogg C, Lucas JS, Camps C, et al. Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis. Eur Respir J. 2022;60(5):2200176.
Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest. 1983;83(1):63–9.
Keicho N, Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am J Respir Med. 2002;1(2):119–31.
Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1990;141(6):1459–62.
Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, et al. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med. 1998;158(3):846–50.
Park MH, Kim YW, Yoon HI, Yoo CG, Han SK, Shim YS, et al. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am J Respir Crit Care Med. 1999;159(2):526–9.
Hijikata M, Matsushita I, Tanaka G, Tsuchiya T, Ito H, Tokunaga K, et al. Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis. Hum Genet. 2011;129(2):117–28.
Hannah WB, Seifert BA, Truty R, Zariwala MA, Ameel K, Zhao Y, et al. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis. Lancet Respir Med. 2022;10(5):459–68.
Keicho N, Hijikata M. Genetic predisposition to diffuse panbronchiolitis. Respirology. 2011;16(4):581–8.
Iso M, Suzuki M, Yanagi K, Minowa K, Sakurai Y, Nakano S, et al. The CFTR gene variants in Japanese children with idiopathic pancreatitis. Hum Genome Var. 2019;6:17.
Martin M, Ebert P, Marschall T. Read-Based Phasing and Analysis of Phased Variants with WhatsHap. Methods Mol Biol. 2023;2590:127–38.
Hijikata M, Morimoto K, Takekoshi D, Shimoda M, Wakabayashi K, Miyabayashi A, et al. Analysis of aberrant splicing events and gene expression outliers in primary ciliary dyskinesia. Am J Respir Cell Mol Biol. 2023;68(6):702–5.
Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6(2):80–92.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24.
Franklin. https://franklin.genoox.com. Accessed 20 Jan 2025.
ClinVar. https://www.ncbi.nlm.nih.gov/clinvar. Accessed 20 Jan 2025.
gnomAD browser. https://gnomad.broadinstitute.org. Accessed 20 Jan 2025.
Kamio K, Matsushita I, Hijikata M, Kobashi Y, Tanaka G, Nakata K, et al. Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis. Am J Respir Crit Care Med. 2005;171(9):949–57.
Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun. 2002;291(1):17–22.
Hoa BK, Hang NT, Kashiwase K, Ohashi J, Lien LT, Horie T, et al. HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam. Tissue Antigens. 2008;71(2):127–34.
Hijikata M, Shojima J, Matsushita I, Tokunaga K, Ohashi J, Hang NT, et al. Association of IFNGR2 gene polymorphisms with pulmonary tuberculosis among the Vietnamese. Hum Genet. 2012;131(5):675–82.
Nam MH, Hijikata M, Tuan LA, Lien LT, Shojima J, Horie T, et al. Variations of the CFTR gene in the Hanoi-Vietnamese. Am J Med Genet A. 2005;136(3):249–53.
De Gracia J, Rodrigo MJ, Morell F, Vendrell M, Miravitlles M, Cruz MJ, et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med. 1996;153(2):650–5.
Handley E, Nicolson CH, Hew M, Lee AL. Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review. J Allergy Clin Immunol Pract. 2019;7(6):2004-12.e1.
Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, et al. Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification. Expert Rev Respir Med. 2013;7(3):289–306.
Martínez-García M, Méndez R, Olveira C, Girón R, García-Clemente M, Máiz L, et al. The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids. Chest. 2023;164(3):606–13.
Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, et al. Characterization of eosinophilic bronchiectasis: a European multicohort study. Am J Respir Crit Care Med. 2022;205(8):894–902.
Choi H, Han K, Jung JH, Park J, Kim BG, Yang B, et al. Impact of rheumatoid arthritis and seropositivity on the risk of non-cystic fibrosis bronchiectasis. Chest. 2024;165(6):1330–40.
Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45(10):1160–7.
Nazarenko MS, Sleptcov AA, Zarubin AA, Salakhov RR, Shevchenko AI, Tmoyan NA, et al. Calling and phasing of single-nucleotide and structural variants of the LDLR gene using Oxford Nanopore MinION. Int J Mol Sci. 2023;24(5):4471.
McClinton B, Watson CM, Crinnion LA, McKibbin M, Ali M, Inglehearn CF, et al. Haplotyping using long-range PCR and nanopore sequencing to phase variants: lessons learned from the ABCA4 locus. Lab Invest. 2023;103(8):100160.
Le VS, Tran KT, Bui HTP, Le HTT, Nguyen CD, Do DH, et al. A Vietnamese human genetic variation database. Hum Mutat. 2019;40(10):1664–75.
Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998;101(2):487–96.
Shen Y, Liu J, Zhong L, Mogayzel PJ Jr, Zeitlin PL, Sosnay PR, et al. Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children. J Pediatr. 2016;171:269-76.e1.
Rumman N, Fassad MR, Driessens C, Goggin P, Abdelrahman N, Adwan A, et al. The Palestinian primary ciliary dyskinesia population: first results of the diagnostic and genetic spectrum. ERJ Open Res. 2023;9(2):00714–2022.
Birkhead M, Otido S, Mabaso T, Mopeli K, Tlhapi D, Verwey C, et al. Ultrastructure for the diagnosis of primary ciliary dyskinesia in South Africa, a resource-limited setting. Front Pediatr. 2023;11:1247638.
Jat KR, Faruq M, Jindal S, Bari S, Soni A, Sharma P, et al. Genetics of 67 patients of suspected primary ciliary dyskinesia from India. Clin Genet. 2024;106(5):650–8.
Kott E, Legendre M, Copin B, Papon JF, Dastot-Le Moal F, Montantin G, et al. Loss-of-function mutations in RSPH1 cause primary ciliary dyskinesia with central-complex and radial-spoke defects. Am J Hum Genet. 2013;93(3):561–70.
Knowles MR, Ostrowski LE, Leigh MW, Sears PR, Davis SD, Wolf WE, et al. Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. Am J Respir Crit Care Med. 2014;189(6):707–17.
Kott E, Duquesnoy P, Copin B, Legendre M, Dastot-Le Moal F, Montantin G, et al. Loss-of-function mutations in LRRC6, a gene essential for proper axonemal assembly of inner and outer dynein arms, cause primary ciliary dyskinesia. Am J Hum Genet. 2012;91(5):958–64.
Davis SD, Rosenfeld M, Lee HS, Ferkol TW, Sagel SD, Dell SD, et al. Primary ciliary dyskinesia: longitudinal study of lung disease by ultrastructure defect and genotype. Am J Respir Crit Care Med. 2019;199(2):190–8.
Shoemark A, Rubbo B, Legendre M, Fassad MR, Haarman EG, Best S, et al. Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia. Eur Respir J. 2021;58(2):2002359.
Fassad MR, Patel MP, Shoemark A, Cullup T, Hayward J, Dixon M, et al. Clinical utility of NGS diagnosis and disease stratification in a multiethnic primary ciliary dyskinesia cohort. J Med Genet. 2020;57(5):322–30.
Raidt J, Riepenhausen S, Pennekamp P, Olbrich H, Amirav I, Athanazio RA, et al. Analyses of 1,236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations. Eur Respir J. 2024;64(2):2301769.
Hai CN, Dinh CT, Duc LT, Quyet TT. Kartagener Syndrome: Three rare cases report and systematic review. J Clin Med Img Case Rep. 2023.
Dougherty GW, Ostrowski LE, Nöthe-Menchen T, Raidt J, Schramm A, Olbrich H, et al. Recessively inherited deficiency of secreted WFDC2 (HE4) causes nasal polyposis and bronchiectasis. Am J Respir Crit Care Med. 2024;210(1):63–76.
He F, Gong HY, Jiang GL, Chen XJ, Yao QJ, Jiang L. Diffuse panbronchiolitis: a case report from a Chinese consanguineous marriage family and literature review. Chron Respir Dis. 2020;17:1479973120961847.
She J, Sun Q, Fan L, Qin H, Bai C, Shen C. Association of HLA genes with diffuse panbronchiolitis in Chinese patients. Respir Physiol Neurobiol. 2007;157(2–3):366–73.
Costain G, Liu Z, Mennella V, Radicioni G, Goczi AN, Albulescu A, et al. Hereditary mucin deficiency caused by biallelic loss of function of MUC5B. Am J Respir Crit Care Med. 2022;205(7):761–8.
Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.